vamsi krishna potluri's most recent trade in SMS Pharmaceuticals Ltd. was a Acquisition of 2,500,000 Equity Shares done at an average price of Rs. 95.3 . Disclosure was reported to the exchange on Sept. 11, 2025 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
vamsi krishna potluri's has made SAST transactions in SMS Pharmaceuticals Ltd. recently where a Pledge of 1,262,590 shares done . Disclosure was reported to the exchange on Dec. 14, 2023.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SMS Pharmaceuticals | Vamsi Krishna Potluri | Promoter Group | Acquisition | 11 Sep 2025 | 2,500,000 | 15,828,370 (16.90%) | 2.82% | 95.3 | 238,125,000 | 10 Sep 2025 10 Sep 2025 |
Insider Trading | Equity Shares | Conversion of security |
| SMS Pharmaceuticals | Vamsi Krishna Potluri | Promoter | Pledge | 24 Dec 2024 | 1,262,590 | 768,000 | - | - | 12 Dec 2023 12 Dec 2023 |
SAST (Reg31) | - | Release | |
| SMS Lifesciences | Vamsi Krishna Potluri | Promoter | Pledge | 24 Dec 2024 | 45,092 | 27,428 | - | - | 12 Dec 2023 12 Dec 2023 |
SAST (Reg31) | - | Release | |
| SMS Pharmaceuticals | Vamsi Krishna Potluri | Promoter | Pledge | 24 Dec 2024 | 768,000 | 0 | - | - | 08 Dec 2023 08 Dec 2023 |
SAST (Reg31) | - | Release | |
| SMS Lifesciences | Vamsi Krishna Potluri | Promoter | Pledge | 24 Dec 2024 | 27,428 | 0 | - | - | 08 Dec 2023 08 Dec 2023 |
SAST (Reg31) | - | Release | |
| SMS Pharmaceuticals | Vamsi Krishna Potluri | Promoter Group | Acquisition | 20 Mar 2024 | 2,500,000 | 15,828,370 (16.90%) | 2.95% | 31.8 | 79,375,000 | 19 Mar 2024 19 Mar 2024 |
Insider Trading | Warrants | Allotment |
| SMS Lifesciences | Vamsi Krishna Potluri | Promoter Group | Revoke | 20 Dec 2023 | 27,428 | 73,234 (2.42%) | 0.91% | 521.4 | 14,300,959 | 08 Dec 2023 08 Dec 2023 |
Insider Trading | Equity Shares | Pledge Released |
| SMS Pharmaceuticals | Vamsi Krishna Potluri | Promoter Group | Revoke | 19 Dec 2023 | 768,000 | 13,328,370 (15.74%) | 0.91% | 118.4 | 90,892,800 | 08 Dec 2023 08 Dec 2023 |
Insider Trading | Equity Shares | Pledge Released |
| SMS Lifesciences | Vamsi Krishna Potluri | Promoter Group | Revoke | 14 Dec 2023 | 45,092 | 73,234 (2.42%) | 1.49% | 517.7 | 23,344,128 | 12 Dec 2023 12 Dec 2023 |
Insider Trading | Equity Shares | Pledge Released |
| SMS Pharmaceuticals | Vamsi Krishna Potluri | Promoter Group | Revoke | 14 Dec 2023 | 1,262,590 | 13,328,370 (15.74%) | 1.49% | 118.9 | 150,121,951 | 12 Dec 2023 12 Dec 2023 |
Insider Trading | Equity Shares | Pledge Released |
| SMS Pharmaceuticals | Vamsi Krishna Potluri (Revised) | Promoter Group | Acquisition | 10 Dec 2020 | 5,317,780 | 13,328,370 (15.74%) | 6.28% | 95.3 | 506,843,749 | 07 Dec 2020 07 Dec 2020 |
Insider Trading | Equity Shares | Inter-se Transfer |
| SMS Pharmaceuticals | Vamsi Krishna Potluri | Promoter Group | Acquisition | 10 Dec 2020 | 5,317,780 | 13,328,370 (15.74%) | 6.28% | 95.3 | 506,843,749 | 07 Dec 2020 07 Dec 2020 |
Insider Trading | Equity Shares | Inter-se Transfer |
| SMS Pharmaceuticals | Vamsi Krishna Potluri, Potluri Infra Projects LLP, Potluri Laboratories Pvt Ltd, TVVSN Murthy HUF, Sudeepthi | Promoter | Acquisition | 26 Nov 2020 | 3,200,000 | 8,010,590 (9.46%) | 3.78% | - | 25 Nov 2020 25 Nov 2020 |
SAST (29(2)) | - | Market | |
| SMS Pharmaceuticals | Vamsi Krishna Potluri | Director | Acquisition | 26 Nov 2020 | 3,200,000 | 8,010,590 (9.46%) | 3.78% | 82.6 | 264,307,750 | 25 Nov 2020 25 Nov 2020 |
Insider Trading | Equity Shares | Market Purchase |